共 50 条
- [42] Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S283 - S284
- [45] THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS NOBEL MEDICUS, 2015, 11 (01): : 87 - 91